 |
Thymoxamine HCl |
|---|---|
| Trade Name | |
| Orphan Indication | Reversal of phenylephrine-induced mydriasis in patients who have narrow anterior angles and are at risk of developing an acute attack of angle-closure glaucoma following mydriasis |
| USA Market Approval | USA |
| USA Designation Date | 1987-11-16 00:00:00 |
| Sponsor | Iolab Pharmaceuticals;500 Iolab Drive;Claremont, California, 94608 |
